Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Petit Drill is a pediatric syrup developed by Pierre Fabre Medicament, specifically formulated to alleviate throat irritation associated with dry cough in infants (from 6 months) and children (up to 6 years). The product is primarily composed of glycerol, which functions as a demulcent. Upon administration, the glycerol forms a protective, lubricating film over the pharyngeal mucosa, which serves to hydrate the throat and reduce the mechanical irritation that triggers coughing. Petit Drill is notable for being sugar-free, colorant-free, and paraben-free, and it is typically classified as a medical device in European markets due to its physical mode of action rather than a pharmacological, immunological, or metabolic one.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Petit Drill.